BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
PRHI
Presurance Holdings, Inc.
There isn't enough reported data to score PRHI yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
PRHI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
PRHI's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like PRHI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | โ |
| Current | 12x | $50.51 | โ |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
PRHI PE Valuation
PRHI has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
PRHI Forward outlook
There aren't enough analyst estimates for PRHI to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over PRHI on earnings quality, reporting a profit while its opponent remains loss making.
PRHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$8.50 | +$6.83 |
| Q2 2026 | -$10.31 | -160% |
| Q1 2026 | -$9.80 | -171% |
| Q4 2025 | -$10.57 | -178% |
| Q3 2025 | -$15.33 | -190% |
| Q2 2025 | $17.15 | +$31.99 |
| Q1 2025 | $13.72 | +$29.05 |
| Q4 2024 | $13.51 | +$28.35 |
PRHI is still losing money, but less than at its worst: $8.50 per share over the past year, against $15.33 at its worst in early 2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over PRHI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over PRHI on profitability, with a higher operating margin.
PRHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.6M | +43% |
| Q2 2026 | $9.1M | -43% |
| Q1 2026 | $11.5M | -27% |
| Q4 2025 | $4.6M | -69% |
| Q3 2025 | $6.7M | -58% |
| Q2 2025 | $16.1M | -40% |
| Q1 2025 | $15.9M | -31% |
| Q4 2024 | $14.7M | -30% |
PRHI's revenue is recovering but still below its 2021 peak: $10M last quarter, up 43% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | +32 points |
| Q2 2026 | 23% | +45 points |
| Q1 2026 | -9.2% | +19 points |
| Q4 2025 | -323% | -144 points |
| Q3 2025 | -44% | +2.1 points |
| Q2 2025 | -23% | -6.4 points |
| Q1 2025 | -28% | -26 points |
| Q4 2024 | -179% | -85 points |
PRHI's operating margin was โ12% last quarter, up 32 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over PRHI on cash generation, producing positive trailing cash flow while its opponent burns cash.
PRHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.5M | -$6.8M |
| Q2 2026 | -$11.9M | -$9.1M |
| Q1 2026 | -$8.3M | +$7M |
| Q4 2025 | -$25.2M | -$5.2M |
| Q3 2025 | -$681K | +$10M |
| Q2 2025 | -$2.8M | +$7.4M |
| Q1 2025 | -$15.3M | -287% |
| Q4 2024 | -$20M | -$7.3M |
PRHI's free cash flow was โ$53M over the past year, against โ$39M the year before. Free cash flow isn't a meaningful measure for financial services companies like PRHI.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
PRHI Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
PRHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.8 | Neutral |
| Stochastic | 45.9 | Neutral |
PRHI's weekly RSI is 46 (neutral) and its Stochastic is 46 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
PRHI PE vs Financial Services Sector
| Metric | PRHI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
PRHI has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
PRHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.15 | 20% below |
| 20 week MA | $6.66 | 14% below |
| 50 week MA | $5.70 | 0.9% above |
| 100 week MA | $6.16 | 6.7% below |
| 200 week MA | $7.48 | 23% below |
PRHI's trend is mixed: it's above one of its five weekly moving averages, and 23% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
PRHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.8 | $18.1 | -37% |
| 2021 | $18.1 | $15.5 | -14% |
| 2022 | $15.5 | $10.8 | -31% |
| 2023 | $10.8 | $7.70 | -29% |
| 2024 | $7.70 | $7.84 | +1.8% |
| 2025 | $7.84 | $5.38 | -31% |
| 2026 YTD | $5.38 | $5.75 | +6.9% |
PRHI has the edge over BAC on returns for 2026, with the stronger performance.